China’s CanSino Biologics and a unit of Sinopharm said Wednesday they have applied for public use of their COVID-19 vaccines, and announced efficacy rates.
Seems everybody has a horror story about health insurance: Kafkaesque debates with robotic agents about what is and isn’t covered. Huge bills from a doctor you […]